These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

337 related articles for article (PubMed ID: 28178667)

  • 1. Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.
    Tivnan A; Heilinger T; Ramsey JM; O'Connor G; Pokorny JL; Sarkaria JN; Stringer BW; Day BW; Boyd AW; Kim EL; Lode HN; Cryan SA; Prehn JH
    Oncotarget; 2017 Mar; 8(10):16605-16620. PubMed ID: 28178667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Post-resection treatment of glioblastoma with an injectable nanomedicine-loaded photopolymerizable hydrogel induces long-term survival.
    Zhao M; Danhier F; Bastiancich C; Joudiou N; Ganipineni LP; Tsakiris N; Gallez B; Rieux AD; Jankovski A; Bianco J; Préat V
    Int J Pharm; 2018 Sep; 548(1):522-529. PubMed ID: 30017818
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth inhibition of estrogen receptor-positive and aromatase-positive human breast cancer cells in monolayer and spheroid cultures by letrozole, anastrozole, and tamoxifen.
    Kijima I; Itoh T; Chen S
    J Steroid Biochem Mol Biol; 2005 Dec; 97(4):360-8. PubMed ID: 16263272
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preparation, characterization, and biodistribution of letrozole loaded PLGA nanoparticles in Ehrlich Ascites tumor bearing mice.
    Mondal N; Halder KK; Kamila MM; Debnath MC; Pal TK; Ghosal SK; Sarkar BR; Ganguly S
    Int J Pharm; 2010 Sep; 397(1-2):194-200. PubMed ID: 20609382
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decitabine nanoconjugate sensitizes human glioblastoma cells to temozolomide.
    Cui Y; Naz A; Thompson DH; Irudayaraj J
    Mol Pharm; 2015 Apr; 12(4):1279-88. PubMed ID: 25751281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
    Dave N; Chow LM; Gudelsky GA; LaSance K; Qi X; Desai PB
    Mol Cancer Ther; 2015 Apr; 14(4):857-64. PubMed ID: 25695958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyaluronic acid-bound letrozole nanoparticles restore sensitivity to letrozole-resistant xenograft tumors in mice.
    Nair HB; Huffman S; Veerapaneni P; Kirma NB; Binkley P; Perla RP; Evans DB; Tekmal RR
    J Nanosci Nanotechnol; 2011 May; 11(5):3789-99. PubMed ID: 21780370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of imatinib loaded surface decorated biodegradable nanocarriers against glioblastoma cell lines: Intracellular uptake and cytotoxicity studies.
    Khan AM; Ahmad FJ; Panda AK; Talegaonkar S
    Int J Pharm; 2016 Jun; 507(1-2):61-71. PubMed ID: 27154254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
    Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
    Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imaging the delivery of brain-penetrating PLGA nanoparticles in the brain using magnetic resonance.
    Strohbehn G; Coman D; Han L; Ragheb RR; Fahmy TM; Huttner AJ; Hyder F; Piepmeier JM; Saltzman WM; Zhou J
    J Neurooncol; 2015 Feb; 121(3):441-9. PubMed ID: 25403507
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nose-to-brain delivery of temozolomide-loaded PLGA nanoparticles functionalized with anti-EPHA3 for glioblastoma targeting.
    Chu L; Wang A; Ni L; Yan X; Song Y; Zhao M; Sun K; Mu H; Liu S; Wu Z; Zhang C
    Drug Deliv; 2018 Nov; 25(1):1634-1641. PubMed ID: 30176744
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized phase II trial of letrozole plus anti-MUC1 antibody AS1402 in hormone receptor-positive locally advanced or metastatic breast cancer.
    Ibrahim NK; Yariz KO; Bondarenko I; Manikhas A; Semiglazov V; Alyasova A; Komisarenko V; Shparyk Y; Murray JL; Jones D; Senderovich S; Chau A; Erlandsson F; Acton G; Pegram M
    Clin Cancer Res; 2011 Nov; 17(21):6822-30. PubMed ID: 21878535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transferrin-modified nanoparticles for targeted delivery of Asiatic acid to glioblastoma cells.
    Ramalho MJ; Bravo M; Loureiro JA; Lima J; Pereira MC
    Life Sci; 2022 May; 296():120435. PubMed ID: 35247437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GD2 targeting by dinutuximab beta is a promising immunotherapeutic approach against malignant glioma.
    Marx S; Wilken F; Wagner I; Marx M; Troschke-Meurer S; Zumpe M; Bien-Moeller S; Weidemeier M; Baldauf J; Fleck SK; Rauch BH; Schroeder HWS; Lode H; Siebert N
    J Neurooncol; 2020 May; 147(3):577-585. PubMed ID: 32246395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoparticle-Delivered Antisense MicroRNA-21 Enhances the Effects of Temozolomide on Glioblastoma Cells.
    Ananta JS; Paulmurugan R; Massoud TF
    Mol Pharm; 2015 Dec; 12(12):4509-17. PubMed ID: 26559642
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of CD133 Targeting Multi-Drug Polymer Micellar Nanoparticles for Glioblastoma - In Vitro Evaluation in Glioblastoma Stem Cells.
    Smiley SB; Yun Y; Ayyagari P; Shannon HE; Pollok KE; Vannier MW; Das SK; Veronesi MC
    Pharm Res; 2021 Jun; 38(6):1067-1079. PubMed ID: 34100216
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting delivery of etoposide to inhibit the growth of human glioblastoma multiforme using lactoferrin- and folic acid-grafted poly(lactide-co-glycolide) nanoparticles.
    Kuo YC; Chen YC
    Int J Pharm; 2015 Feb; 479(1):138-49. PubMed ID: 25560309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Additive antitumor effect of aromatase inhibitor letrozole and antiestrogen fulvestrant in a postmenopausal breast cancer model.
    Jelovac D; Macedo L; Goloubeva OG; Handratta V; Brodie AM
    Cancer Res; 2005 Jun; 65(12):5439-44. PubMed ID: 15958593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-neuroblastoma effect of ch14.18 antibody produced in CHO cells is mediated by NK-cells in mice.
    Zeng Y; Fest S; Kunert R; Katinger H; Pistoia V; Michon J; Lewis G; Ladenstein R; Lode HN
    Mol Immunol; 2005 Jul; 42(11):1311-9. PubMed ID: 15950727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase inhibitor letrozole in synergy with curcumin in the inhibition of xenografted endometrial carcinoma growth.
    Liang YJ; Hao Q; Wu YZ; Wang QL; Wang JD; Hu YL
    Int J Gynecol Cancer; 2009 Oct; 19(7):1248-52. PubMed ID: 19823063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.